Florida Trust Wealth Management Co Sells 715 Shares of McKesson Corporation $MCK

Florida Trust Wealth Management Co cut its stake in shares of McKesson Corporation (NYSE:MCK) by 1.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 36,352 shares of the company’s stock after selling 715 shares during the period. Florida Trust Wealth Management Co’s holdings in McKesson were worth $29,819,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in MCK. Obsidian Personal Planning Solutions LLC lifted its holdings in McKesson by 2.9% during the 3rd quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company’s stock worth $346,000 after purchasing an additional 12 shares during the last quarter. IAM Advisory LLC grew its holdings in McKesson by 0.3% in the 3rd quarter. IAM Advisory LLC now owns 3,908 shares of the company’s stock valued at $3,019,000 after buying an additional 13 shares in the last quarter. PDS Planning Inc increased its position in McKesson by 1.1% during the 3rd quarter. PDS Planning Inc now owns 1,209 shares of the company’s stock worth $934,000 after buying an additional 13 shares during the period. Berkshire Asset Management LLC PA increased its position in McKesson by 4.6% during the 3rd quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company’s stock worth $227,000 after buying an additional 13 shares during the period. Finally, Norden Group LLC lifted its holdings in shares of McKesson by 4.3% during the fourth quarter. Norden Group LLC now owns 317 shares of the company’s stock worth $260,000 after buying an additional 13 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. TD Cowen boosted their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a research note on Thursday, January 29th. Evercore reissued an “outperform” rating on shares of McKesson in a report on Thursday, March 5th. Finally, Robert W. Baird set a $968.00 target price on shares of McKesson in a report on Wednesday, January 14th. Thirteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $960.93.

Insider Activity

In related news, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the transaction, the executive vice president owned 2,268 shares in the company, valued at $1,851,096.24. This trade represents a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 3,868 shares of company stock valued at $3,743,820. 0.08% of the stock is currently owned by company insiders.

McKesson Price Performance

Shares of McKesson stock opened at $885.42 on Friday. The company’s 50 day moving average price is $912.57 and its two-hundred day moving average price is $845.61. The firm has a market capitalization of $108.45 billion, a P/E ratio of 25.46, a P/E/G ratio of 1.26 and a beta of 0.42. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the prior year, the business earned $8.03 earnings per share. The company’s revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts expect that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd were given a $0.82 dividend. The ex-dividend date was Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.